Your session is about to expire
← Back to Search
Behavioral Intervention
Hypnosis and Music Therapy for Palliative Care (MuzhypforPC Trial)
N/A
Recruiting
Led By Josiane Bissonnette, Ph.D
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year.
Awards & highlights
MuzhypforPC Trial Summary
This trial will study the effectiveness of a therapy program of hypnosis, music, or both combined, to improve palliative care for people at home. Results will measure pain, anxiety, & unwellness levels.
Who is the study for?
This trial is for individuals in end-of-life palliative care at home, who can communicate well and have satisfactory hearing (with or without aids). They should be moderately active, scoring between 30% to 79% on the Karnofsky Performance Index. People with severe neurocognitive or psychotic disorders cannot participate.Check my eligibility
What is being tested?
The study tests a personalized program called MuzHyp that uses hypnosis and music separately or together to see if they help reduce pain, anxiety, and feelings of unwellness in palliative care patients. The effects are measured right after treatment using the Edmonton symptom assessment scale.See study design
What are the potential side effects?
Since this intervention involves non-invasive techniques like hypnosis and music therapy, side effects are minimal but may include discomfort due to unfamiliarity with the methods or emotional responses triggered during sessions.
MuzhypforPC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in Composite pain, anxiety, and unwellness score
Secondary outcome measures
Changes in Anxiety levels
Changes in Appetite
Changes in Depression levels
+9 moreOther outcome measures
Subjective experience
MuzhypforPC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized multimodal intervention involving hypnosis and/or musicExperimental Treatment1 Intervention
This arm will receive a personalized multimodal intervention involving (a) hypnosis, (b) music or (c) hypnosis and music.
Note that the objective of the research is not to compare the effect of the different intervention modalities between them, but to consider these three modalities as a multimodal intervention taking into consideration patients' preferences, that we compare to the control.
Group II: Control/Waiting listActive Control1 Intervention
The participants of the control group will carry out its their daily activities and will be assessed using the same measures, at the beginning of each session and after a delay comparable to the duration of the intervention administered in the experimental group.
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,232 Total Patients Enrolled
Université de MontréalOTHER
214 Previous Clinical Trials
102,731 Total Patients Enrolled
Josiane Bissonnette, Ph.DPrincipal InvestigatorLaval University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are receiving end-of-life care at home.Your overall physical condition is between 30% and 79% on a scale that measures your ability to perform daily activities.You have severe mental disorders that affect your thinking and behavior.
Research Study Groups:
This trial has the following groups:- Group 1: Personalized multimodal intervention involving hypnosis and/or music
- Group 2: Control/Waiting list
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment currently underway for this clinical investigation?
"Per the data on clinicaltrials.gov, this study is presently seeking individuals to participate in their medical trial. The initial posting of the trial was seen April 13th 2022, and it has been recently adjusted on July 10th 2023."
Answered by AI
How many participants are engaging in this experiment?
"Affirmative. Verification from clinicaltrials.gov suggests that the trial, which initially launched on April 13th 2022, is currently seeking eligible participants. 40 people will be admitted at two separate medical sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger